Multiple Myeloma with Biotech Carvykti
Carvykti, developed by Janssen Biotech, is a type of immunotherapy for adult patients with Multiple Myeloma. Through Carvykti therapy, a patient's T-cells are genetically reprogrammed to fight cancer cells.
1 Result(s)
Distance
1171 Miles
Details